help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lappas, M.
Right arrow Articles by Rice, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lappas, M.
Right arrow Articles by Rice, G. E.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 11 5627-5633
Copyright © 2004 by The Endocrine Society

Release of Proinflammatory Cytokines and 8-Isoprostane from Placenta, Adipose Tissue, and Skeletal Muscle from Normal Pregnant Women and Women with Gestational Diabetes Mellitus

Martha Lappas, Michael Permezel and Gregory E. Rice

Department of Obstetrics and Gynecology, University of Melbourne and Mercy Perinatal Research Center, Mercy Hospital for Women, East Melbourne, 3002 Victoria, Australia

Address all correspondence and requests for reprints to: Dr. Martha Lappas, Department of Obstetrics and Gynecology, University of Melbourne, Mercy Hospital for Women, 126 Clarendon Street, East Melbourne, 3002 Victoria, Australia. E-mail: mlappas{at}unimelb.edu.au.

The aim of this study was to 1) profile the basal release of TNF-{alpha}, IL-6, IL-8, and 8-isoprostane (a marker of oxidative stress); and 2) investigate the effect of stimulation on the release of cytokines from sc adipose tissue and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus (GDM). Placenta, sc adipose tissue, and skeletal muscle were incubated in the absence (control) or presence of lipopolysaccharide (LPS; 10 µg/ml), TNF-{alpha} (10 ng/ml), IL-6 (10 ng/ml), or IL-8 (10 ng/ml). After an 18-h incubation, the medium was collected, and the release of TNF-{alpha}, IL-6, IL-8, and 8-isoprostane was quantified by ELISA. In all three tissues, 8-isoprostane release was greater in women with GDM, and stimulation with LPS increased 8-isoprostane release from adipose and skeletal muscle, but not placenta, obtained from women with GDM. However, in tissues obtained from normal pregnant women, LPS stimulation increased 8-isoprostane release in placenta and had no effect in adipose tissue and skeletal muscle. Their was no difference in the release of TNF-{alpha}, IL-6, and IL-8 from placenta, adipose tissue, and skeletal muscle obtained from normal pregnant women and women with GDM. Stimulation of placenta, adipose tissue, and skeletal muscle with LPS and TNF-{alpha} resulted in greater release of IL-6 and IL-8, whereas only LPS increased TNF-{alpha} release from all three tissues. The data presented in this study demonstrate that there is a differential release of 8-isoprostane from fetal (placenta) and maternal (adipose tissue and skeletal muscle) tissues obtained from normal pregnant women and women with GDM. These data are consistent with the hypothesis that oxidative stress may be involved in the progression and/or pathogenesis of GDM.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. H. V. Remels, R. C. J. Langen, H. R. Gosker, A. P. Russell, F. Spaapen, J. W. Voncken, P. Schrauwen, and A. M. W. J. Schols
PPAR{gamma} inhibits NF-{kappa}B-dependent transcriptional activation in skeletal muscle
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E174 - E183.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Colomiere, M. Permezel, C. Riley, G. Desoye, and M. Lappas
Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus
Eur. J. Endocrinol., April 1, 2009; 160(4): 567 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. L. Magnusson-Olsson, B. Hamark, A. Ericsson, M. Wennergren, T. Jansson, and T. L. Powell
Gestational and hormonal regulation of human placental lipoprotein lipase
J. Lipid Res., November 1, 2006; 47(11): 2551 - 2561.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Lappas, K. Yee, M. Permezel, and G. E Rice
Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies
J. Endocrinol., September 1, 2005; 186(3): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Lappas, M. Permezel, and G. E. Rice
Leptin and Adiponectin Stimulate the Release of Proinflammatory Cytokines and Prostaglandins from Human Placenta and Maternal Adipose Tissue via Nuclear Factor-{kappa}B, Peroxisomal Proliferator-Activated Receptor-{gamma} and Extracellularly Regulated Kinase 1/2
Endocrinology, August 1, 2005; 146(8): 3334 - 3342.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society